Zymeworks Inc. (NYSE: ZYME) announced today the pricing of its previously- announced underwritten public offering of 5,400,000 common shares at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE